Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Caffeine vs Supportive Therapy for AKI Prevention in Preterm Neonates
NCT07305935Completed
- Start
- Oct 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of caffeine in acute kidney injury (AKI) (2 arms). Primary endpoint: Acute Kidney Injury at 14 days. Started Oct 2025; status: completed.
02
Drugs
caffeine
03
Conditions
acute kidney injury (AKI)
Beyond the preview
Go deeper on NCT07305935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07305935.